Cargando…

MiRNA expression patterns predict survival in glioblastoma

BACKGROUND: In order to define new prognostic subgroups in patients with glioblastoma a miRNA screen (> 1000 miRNAs) from paraffin tissues followed by a bio-mathematical analysis was performed. METHODS: 35 glioblastoma patients treated between 7/2005 - 8/2008 at a single institution with surgery...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niyazi, Maximilian, Zehentmayr, Franz, Niemöller, Olivier M, Eigenbrod, Sabina, Kretzschmar, Hans, Osthoff, Klaus-Schulze, Tonn, Jörg-Christian, Atkinson, Mike, Mörtl, Simone, Belka, Claus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235977/ https://www.ncbi.nlm.nih.gov/pubmed/22074483 http://dx.doi.org/10.1186/1748-717X-6-153

Ejemplares similares

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

The number of methylated CpG sites within the MGMT promoter region linearly correlates with outcome in glioblastoma receiving alkylating agents
por: Siller, Sebastian, et al.
Publicado: (2021)

MicroRNA expression profiles in human cancer cells after ionizing radiation
por: Niemoeller, Olivier M, et al.
Publicado: (2011)

Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status
por: Unger, Kristian, et al.
Publicado: (2020)

Current status and recent advances in reirradiation of glioblastoma
por: Minniti, Giuseppe, et al.
Publicado: (2021)

Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
por: Teske, Nico, et al.
Publicado: (2023)

Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence
por: Zakaria, Rasheed, et al.
Publicado: (2016)

Current concepts in clinical radiation oncology
por: Orth, Michael, et al.
Publicado: (2013)

Krüppel-Like Factor 8 (KLF8) Is Expressed in Gliomas of Different WHO Grades and Is Essential for Tumor Cell Proliferation
por: Schnell, Oliver, et al.
Publicado: (2012)

Counting colonies of clonogenic assays by using densitometric software
por: Niyazi, Maximilian, et al.
Publicado: (2007)

Hippocampal EUD in primarily irradiated glioblastoma patients
por: Bodensohn, Raphael, et al.
Publicado: (2014)

Isobologram analysis of triple therapies
por: Niyazi, Maximilian, et al.
Publicado: (2006)

Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre
por: Wolf, Maria C, et al.
Publicado: (2012)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
por: Hadi, Indrawati, et al.
Publicado: (2021)

Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?
por: Niyazi, Maximilian, et al.
Publicado: (2015)

Hippocampal sparing radiotherapy for glioblastoma patients: a planning study using volumetric modulated arc therapy
por: Hofmaier, Jan, et al.
Publicado: (2016)

O(6)-Methylguanine-DNA Methyltransferase (MGMT) mRNA Expression Predicts Outcome in Malignant Glioma Independent of MGMT Promoter Methylation
por: Kreth, Simone, et al.
Publicado: (2011)

Choline PET based dose-painting in prostate cancer - Modelling of dose effects
por: Niyazi, Maximilian, et al.
Publicado: (2010)

Curative treatment of oesophageal carcinoma: current options and future developments
por: Wolf, Maria C, et al.
Publicado: (2011)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011)

Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients
por: Niyazi, Maximilian, et al.
Publicado: (2014)

Stereotactic Radiosurgery of Multiple Brain Metastases: A Review of Treatment Techniques
por: Bodensohn, Raphael, et al.
Publicado: (2023)

Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
por: Schnöller, Leon Emanuel, et al.
Publicado: (2022)

Mature results of a randomized trial comparing two fractionation schedules of high dose rate endoluminal brachytherapy for the treatment of endobronchial tumors
por: Niemoeller, Olivier M, et al.
Publicado: (2013)

Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions
por: Marini, Patrizia, et al.
Publicado: (2009)

Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2013)

Multimodal therapy of cavernous sinus meningioma: Impact of surgery and (68)Ga-DOTATATE PET-guided radiation therapy on tumor control and functional outcome
por: Hadi, Indrawati, et al.
Publicado: (2021)

Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov
por: Cihoric, Nikola, et al.
Publicado: (2017)

IκBζ is a Key Regulator of Tumour Necrosis Factor-α and Interleukin-17A-mediated Induction of Interleukin-36η in Human Keratinocytes
por: OVESEN, Sofie Kaas, et al.
Publicado: (2021)

How we treat glioblastoma
por: Weller, Michael, et al.
Publicado: (2019)

Contrast-enhanced, conebeam CT-based, fractionated radiotherapy and follow-up monitoring of orthotopic mouse glioblastoma: a proof-of-concept study
por: Stegen, Benjamin, et al.
Publicado: (2020)

Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT
por: Niyazi, Maximilian, et al.
Publicado: (2013)

Current status and perspectives of interventional clinical trials for brain metastases: analysis of ClinicalTrials.gov
por: Tini, Paolo, et al.
Publicado: (2023)

Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma
por: Albert, Nathalie L., et al.
Publicado: (2023)

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic (18)F-FET PET?
por: Unterrainer, Marcus, et al.
Publicado: (2021)

Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status
por: Weller, Jonathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ol685nq1gssrgqhfbm8j0n4kqs